First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma.

about

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for the treatment of malignant mesothelioma.

P2860

Q52579981-3DF4557F-CA65-4111-8B8B-00F7A4DCDCE4

P2860

First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma.

Item

http://www.wikidata.org/entity/Q47868774

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

First-line chemotherapy with p ...... gnant peritoneal mesothelioma.

@en

First-line chemotherapy with p ...... gnant peritoneal mesothelioma.

@nl

type

Item

label

First-line chemotherapy with p ...... gnant peritoneal mesothelioma.

@en

First-line chemotherapy with p ...... gnant peritoneal mesothelioma.

@nl

prefLabel

First-line chemotherapy with p ...... gnant peritoneal mesothelioma.

@en

First-line chemotherapy with p ...... gnant peritoneal mesothelioma.

@nl

P1476

First-line chemotherapy with p ...... gnant peritoneal mesothelioma.

@en

P2093

Eriko Fujimoto

http://www.w3.org/2001/XMLSchema#string

Hiroshi Doi

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Kitajima

http://www.w3.org/2001/XMLSchema#string

Koji Mikami

http://www.w3.org/2001/XMLSchema#string

Kozo Kuribayashi

http://www.w3.org/2001/XMLSchema#string

Shingo Kanemura

http://www.w3.org/2001/XMLSchema#string

Takashi Kijima

http://www.w3.org/2001/XMLSchema#string

Takashi Nakano

http://www.w3.org/2001/XMLSchema#string

Yoshiki Negi

http://www.w3.org/2001/XMLSchema#string

P2860

Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction

Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report.

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

Advances in the management of peritoneal mesothelioma

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

The epidemiology of mesothelioma.

Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.

Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent.

Consensus statement on peritoneal mesothelioma.

A Histomorphologic Grading System That Predicts Overall Survival in Diffuse Malignant Peritoneal Mesothelioma With Epithelioid Subtype

P304

865-872

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737140.2017.1340157

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28594258

http://www.w3.org/2001/XMLSchema#string

First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma.

about

P2860

P2860

First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698